Schedule 13G ownership disclosure

ENVVENO MEDICAL CORPORATION

Common Stock, $0.00001 par value per share · CUSIP: 29415J205

Event date: 2026-09-30

Filing-level shares
33,470.00
Percent of class
4.8%
  • Thomas A. Satterfield, Jr.

    Shares: 33,470.00 · Class: 4.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-26-125054
Form type
SCHEDULE 13G/A
Filer
enVVeno Medical Corp
CIK
CIK 1661053
Filed
Nov 10, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub